Miracle
Miracle gives clinical operations teams a single place to replace spreadsheets, track trials, and surface real-time issues so studies stay on schedule. It is a B2B SaaS clinical trial operations platform that integrates clinical trial systems and external vendors into a unified dashboard with real-time analytics and vendor oversight. The platform connects to existing trial tools and goes live in days to consolidate trackers, timelines, and vendor metrics. Typical customers are clinical-stage biotech and pharmaceutical operations teams using Miracle to accelerate study timelines and reduce manual coordination.
Miracle
Miracle gives clinical operations teams a single place to replace spreadsheets, track trials, and surface real-time issues so studies stay on schedule. It is a B2B SaaS clinical trial operations platform that integrates clinical trial systems and external vendors into a unified dashboard with real-time analytics and vendor oversight. The platform connects to existing trial tools and goes live in days to consolidate trackers, timelines, and vendor metrics. Typical customers are clinical-stage biotech and pharmaceutical operations teams using Miracle to accelerate study timelines and reduce manual coordination.
TL;DR
Sector: Clinical-trial operations SaaS
Founded: 2022
Headquarters: San Francisco, CA
Founder / CEO: Jin Kim
Notable investors: Y Combinator; SBXi
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Clinical trial operations and coordination for clinical-stage biotech and pharmaceutical teams.
Founded
2022
Industry
Biotechnology Research
Tech Stack
Funding Track Record
Investors reported include Y Combinator and SBXi.
Investor Signal
“Y Combinator; SBXi; additional investors reported by some sources include E14 Fund and North South Ventures”